World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 18 June 2018
Main ID:  ISRCTN45787990
Date of registration: 22/05/2018
Prospective Registration: No
Primary sponsor: Ibis Reproductive Health
Public title: Improving access to safe abortion in Indonesia
Scientific title: Effect of a smartphone application on abortion preparedness and feelings of support compared to standard counseling among callers to a safe abortion hotline in Indonesia seeking information on medication abortion
Date of first enrolment: 01/02/2017
Target sample size: 500
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN45787990
Study type:  Interventional
Study design:  Single-center randomized control trial (Other)  
Phase: 
Countries of recruitment
Indonesia
Contacts
Name: Caitlin    Gerdts
Address:  1330 Broadway Suite 1100 94612 Oakland United States of America
Telephone:
Email:
Affiliation: 
Name: Ruvani    Jayaweera
Address:  1330 Broadway Suite 1100 94612 Oakland United States of America
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. At least 15 years old
2. Able to give informed consent
3. Able to speak Bahasa Indonesia or English
4. Contact the hotline seeking information about medications for induced abortion and are 13 weeks gestation or below
5. Starting a new medication abortion process
6. Own an Android or iPhone smartphone
7. Willing to download a third-party application and receive SMS messages

Exclusion criteria: 1. Call the hotline but have already started their abortion process
2. Aged younger than 15
3. Do not own a smartphone


Age minimum:
Age maximum:
Gender: Female
Health Condition(s) or Problem(s) studied
Abortion
Pregnancy and Childbirth
Self-managing their abortion with medication
Intervention(s)
Eligible participants who contact a safe abortion hotline for information on first trimester medication abortion are randomized into two study arms:
Intervention Arm: participants in this group receive standard of care from the safe abortion hotline. This consists of comprehensive, reliable, and accurate information and support to women who are seeking information on how to self-manage their abortion. Participants in this group also have access to a third-party smartphone application which is downloaded via a link. This contains information on medication abortion protocols, what to expect, warning signs and complications, contraception, healthy relationships, and other sexual and reproductive health related topics.

Control Arm: Participants in this group receive standard care of telephonic support from hotline counselors, which includes compassionate, gestational specific counseling on evidence-based medication abortion protocols, what to expect, how to manage symptoms and side effects, and warning signs of complications.
Primary Outcome(s)
1.Preparedness for abortion symptoms/what to expect
2. Confidence in following the abortion regimen
3. Feeling supported during the process
All outcome measures are assessed using an online questionnaire three weeks after randomization.
Secondary Outcome(s)
1. Number of times contacted the hotline during their abortion process
Secondary ID(s)
INDO 05216
Source(s) of Monetary Support
David and Lucile Packard Foundation
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Allendale Institutional Review Board, 28/04/2016, no public reference number available.
Results
Results available: Yes
Date Posted:
Date Completed: 31/12/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history